Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo-Geum Kong

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|June 23, 2011
Bone mineral density and osteoporosis risk in older patients with schizophreniaDo-Un Jung, Deanna L Kelly, Min-Kyung Oh, et al.
Psychiatry and Clinical Neurosciences|May 22, 2009
Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesiaSung Woo Park, Jung Goo Lee, Bo Geum Kong, et al.
Schizophrenia Research|August 21, 2016
Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trialDong-Wook Jeon, Joo-Cheol Shim, Bo-Geum Kong, et al.
Psychiatry Investigation|August 3, 2016
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive DisorderWoo-Young Jung, Sae-Heon Jang, Sung-Gon Kim, et al.
International Journal of Psychiatry in Clinical Practice|September 22, 2015
Differences in cognitive function and daily living skills between early- and late-stage schizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Dementia and Geriatric Cognitive Disorders|April 16, 2005
Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patientsTae Min Ha, Deuk Man Cho, Sung Woo Park, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 25, 2015
The Relationship between Language Ability and Cognitive Function in Patients with SchizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 4, 2011
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trialJoo-Cheol Shim, Do-Un Jung, Sung-Soo Jung, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|June 23, 2011
Bone mineral density and osteoporosis risk in older patients with schizophreniaDo-Un Jung, Deanna L Kelly, Min-Kyung Oh, et al.
Psychiatry and Clinical Neurosciences|May 22, 2009
Genetic association of BDNF val66met and GSK-3beta-50T/C polymorphisms with tardive dyskinesiaSung Woo Park, Jung Goo Lee, Bo Geum Kong, et al.
Schizophrenia Research|August 21, 2016
Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trialDong-Wook Jeon, Joo-Cheol Shim, Bo-Geum Kong, et al.
Psychiatry Investigation|August 3, 2016
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive DisorderWoo-Young Jung, Sae-Heon Jang, Sung-Gon Kim, et al.
International Journal of Psychiatry in Clinical Practice|September 22, 2015
Differences in cognitive function and daily living skills between early- and late-stage schizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Dementia and Geriatric Cognitive Disorders|April 16, 2005
Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patientsTae Min Ha, Deuk Man Cho, Sung Woo Park, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 25, 2015
The Relationship between Language Ability and Cognitive Function in Patients with SchizophreniaSung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 4, 2011
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trialJoo-Cheol Shim, Do-Un Jung, Sung-Soo Jung, et al.
Pageof 1